Citigroup Inc Portage Biotech Inc. Transaction History

Citigroup Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$6.81 - $136.4 $306 - $6,138	-45 Reduced 16.85%	222 $2,000
Q2 2022 Aug 10, 2022	SELL	$5.16 - $11.95 $743 - $1,720	-144 Reduced 35.04%	267 $2,000
Q1 2022 May 12, 2022	SELL	$6.57 - $12.0 $7,522 - $13,740	-1,145 Reduced 73.59%	411 $2,000
Q4 2021 Feb 10, 2022	BUY	$10.73 - $23.74 $14,635 - $32,381	1,364 Added 710.42%	1,556 $17,000
Q3 2021 Nov 10, 2021	BUY	$13.65 - $22.4 $2,620 - $4,300	192 New	192 $4,000

28.4K

Ticker PRTG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,943,700
Market Cap $70.3M
Description
Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a smal...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.